22 October 2019
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Peter van Lent, theme Inflammatory diseases, will focus on novel tools for imaging of early synovial activation for diagnostic and therapeutic purposes in osteoarthritis.
Fons van de Loo, theme Inflammatory diseases, will focus on the role of TAM receptor tyrosine kinases in osteoarthritis and treat this disease by activating this negative feedback system.
Two projects were granted by the Dutch Arthritis Association (ReumaNederland) for Experimental Rheumatology.
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Peter van Lent, theme Inflammatory diseases, will focus on novel tools for imaging of early synovial activation for diagnostic and therapeutic purposes in osteoarthritis.
Fons van de Loo, theme Inflammatory diseases, will focus on the role of TAM receptor tyrosine kinases in osteoarthritis and treat this disease by activating this negative feedback system.